Just 18 months after a multidistrict litigation (MDL) was formed, Boehringer Ingelheim International GmbH is now facing more than 2,000 lawsuits in the U.S. over severe bleeding and other in... Read more
An Illinois federal judge has ordered Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) to pay nearly $1 million as sanctions for discovery abuses in multidistrict litigation (MDL) involving... Read more
Boehringer Ingelheim Pharmaceuticals will pay $95 million to settle a False Claims Act charge brought to the government’s attention by a sales representative-turned-whistleblower. The whistl... Read more
The Massachusetts Attorney General’s Office has reached a settlement with Boehringer Ingelheim Roxane, Inc. (Roxane), a Columbus, Ohio-based drug manufacturer, in a False Claims Act case. Un... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.